The global recombinant veterinary vaccine market size was valued at USD 1.37 billion in 2024 and is projected to reach USD 2.39 billion by 2032, with a CAGR of 7.22% during the forecast period of 2025 to 2032.
Read MoreThe Middle East molecular point of care testing (using NAAT) market size was valued at USD 274.00 million in 2024 and is expected to reach USD 484.16 million by 2032, at a CAGR of 7.4% during the forecast period
Read MoreThe Africa molecular point of care testing (using NAAT) market size was valued at USD 345.45 million in 2024 and is expected to reach USD 542.33 million by 2032, at a CAGR of 5.8% during the forecast period
Read MoreThe Europe molecular point of care testing (using NAAT) market size was valued at USD 2.16 billion in 2024 and is expected to reach USD 4.91 billion by 2032, at a CAGR of 10.8% during the forecast period
Read MoreThe North America Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices market size was valued at USD 1.89 billion in 2024 and is expected to reach USD 3.68 billion by 2032, at a CAGR of 8.7% during the forecast period
Read More